Immunocompetent Mouse Models of Multiple Myeloma

Immunocompetent mouse models of multiple myeloma (MM) are particularly needed in the era of T  cell redirected therapy to understand drivers of sensitivity and resistance, optimize responses, and prevent toxicities. Three mouse models have been extensively characterized: the Balb/c plasmacytomas, the 5TMM, and the Vk*MYC. In the last year, additional models have been generated, which, for t he first time, capture primary MM initiating events, like MMSET/NSD2 or cyclin D1 dysregulation. However, the long latency needed for tumor development and the lack of transplantable lines limit their utilization. Future studies should focus on modeling hyperdiploid MM.
Source: Hematology/Oncology Clinics of North America - Category: Cancer & Oncology Authors: Source Type: research